Interpace Biosciences, Inc. (IDXG): Cost of Revenue
$14.60M
Year ended 2025-12-31
$13.10M
Trailing 12 months to 2026-06-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.60M | -14.1% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $17.00M | +13.5% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $14.98M | n/c | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $13.61M | -4.9% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $14.31M | n/c | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $21.67M | +36.4% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $15.89M | +55.8% | 2021-04-01, From 2019-01-01 |
| 2018-12-31 | $10.20M | +38.6% | 2021-01-19, From 2018-01-01 |
| 2017-12-31 | $7.36M | +10.8% | 2018-03-23, From 2017-01-01 |
| 2016-12-31 | $6.64M | -3.9% | 2018-03-23, From 2016-01-01 |
| 2015-12-31 | $6.91M | +445.0% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $1.27M | n/a | 2016-03-30, From 2014-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $14.60M | -14.1% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $16.52M | -1.4% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $38.22M | +12.2% |
| Cytosorbents Corp (CTSO) | 2025-12-31 | $10.57M | -1.3% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $14.28M | +16.4% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $15.52M | +26.1% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $22.94M | +88.1% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $10.08M | +24.7% |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $190.0K | -6.9% |
Compare IDXG, UTMD, RVP, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗